If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
DERMATOLOGY
EMJ Dermatol. 2019 Suppl 1 • europeanmedical-journal.com
INSIDE
Unlocking the Potential of Immuno-
Oncology in Advanced Cutaneous
Squamous Cell Carcinoma: Role of
Checkpoint Blockade
Unlocking the Potential of Immuno-Oncology in
Advanced Cutaneous Squamous Cell Carcinoma:
Role of Checkpoint Blockade
This satellite symposium took place on 14th September 2018,
as part of the European Academy of Dermatology and
Venereology (EADV) Congress in Paris, France
Chairpeople: Caroline Robert,1 Michael Migden2
Speakers: Caroline Robert,1 Ketty Peris,3 Michael Migden2
1. Institut Gustave Roussy, Villejuif, France
2. MD Anderson Cancer Center, Houston, Texas, USA
3. Università Cattolica del Sacro Cuore, Rome, Italy
Disclosure: Dr Peris has received grants from AbbVie and has serve
DERMATOLOGY EMJ Dermatol. 2019 Suppl 1 • european
Unlocking the Potential of Immuno-Oncology in Adv
Understanding Cutaneous Squamous Cell Carcinoma D
In summary, the frequency and rising incidence of
Existing Treatment Approaches for the Man
rates and lack of consistent reporting
In summary, there are currently no approved syste
endocrine glands, skin, and liver.44,45 Events ar
delegates voting that chemotherapy alone
immunology: The cancer-immunity cycle. Immunity 2